The combination of GLP-1RA with metformin, in contrast to metformin alone or metformin plus insulin, improved lung function (FEV1, FVC) in a prospective cohort of 32 patients with diabetes who did not have lung disease [58]. The gene discussed is INS; the disease is diabetes mellitus.